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BelOg the m ~f frequent IOlcctiom in d,e community.
respiratory tl'3et mlcetiom are responsIble for an important
part ofantibiOtiC consumption. Anllhi tics th~c are ro be iven
to a large p rt of the c mmunicy (pamcularly very young or
very old patients) ~hould be al rht: s.m' time work (as fi dur
re ult in more comumption. 5 well as spre. d of the p, thogenic
organisms) and b extremely ~afe. mldering th.1t much
antibiotic consumption in respil'3tory tract infections occurs in
p flel1tS WIth 110 Deed t all of antibIotic dlcrapy, orlly almo t
totally nontoxic drugs should be used. It has been said
(jokingly) lhal antibIotics to be recommended in rc-~pirar ry
cract infections should be so s: fe tho t the bcnel'i hould h. y
excccd the Ii ks. even in uIlLJ,fecfed. healthy individu.ls.
An imp rtant problem in the evaJuanon of the usefulness of
annblotl m upper rcspiotOry tract mfe DOns i the high
spontaneous cure rate. Up to 800,1, of acute otItis media ill
cluldren 10 dtfferent !nab resolvl:' Without antlbi ric therapy,
cncouragll1g the Jppli ati n of polic:'i, of r :'iO' oW ll~e of
antibil)ocs in me counmc.:s. The incidcn co of sp 11 ne U>
rcsolucioll differs cording to the etiological or~lOi~nJ: the figure
~ orlly 20°;" in acute otici. media c3ust'd by Irrplo({)cCl/S
1'"I'II"'O"'tI(. 5(~Yo where HilCIIIOphillls ,,!f1l1ellztll' is lI1volved, and
rru re.1ch 80% if ml' camal p th 1gen is lv/(}TIIX/'I/tl ctl/tI"htllis.
IInilarly, pontaneous cure l':1te..~ in . pyog/'lIr ton iIJophar-
yngitl may reach 40"/rr-S % in llIe ~eri [1]. Nevenhdc s.
de Ferr.mc el al. 12]. in. re ellt mer.l-analysi of ut inusltls.
showed th.1t the IJ.'iC of antibiotics provided weater benefit t the
patielll'i tlun placebo, but nly ntinlllL1.I dJiferences 111 tI'e out ome
were fowld !:It:tween oral pem illms and oral ephalosp nns.
The rrl:'arment ofacure pharyngitis with oral ceph. I sporim
c;lU\ed by 13-hemolycic . pyogmrs (GAB IS) cau. ed a
comr ve y th t caned in 199 and 1sred for a wh Ie decade
I I· TI'e key r ull f met:l- naly.· of 19 mJdies c rric:d llt
by PI hichero et al. 141 was lhal 'oml cephaJospori05 have
produced consistently superior bacten logi lire when
compared with oral penicillin for treatment of .ABH
pharyngitis'. In thl mct.1-analysis. 16% f b3cteno]ugi aI
failures cCllrred among 1169 peni ilIill-creatc I pancn ,and
rIly 8% mong 12 0 patien created with oral cephalosporim.
Markowitz [5-7J p inted our that many ofthesc patients could
- rr~onding uthor and repnnr te'lu<:$ : M. . Negri, Dep3l'1:llIenr
of MlcroblOl0ltY. Rambn y CahaJ H SplCll!' Madnd, paUl
be c midc:red ,s ABH carners. and n It rC3Uy be Ulfe ted.
and it I wclJ known lhat carriage . Pl'o.~C'III!S is very difficult to
e "di are wim peruciJlin.
T, reo sons for the cluueal upcnonty sh ukl be COl S1dCl\:d.
Fi~t. dle Inte&n:nce hypom~.: crCI t· US f the \'iridan.~
group llI:ly Interfere wid, GABF-I. 10Iliz: ci n m the pharynx
[!l.9J. As moe virid11lS strL>pt occi arc l1Iore resistant to
c<.>ph.1Iospocim m:m to penicillins, a certain degree of ·vmclanc;.
mediated ,A13HS coJunizarion res15tJJlce' would be rellloved b
the lI5e of nicillins. allowing GADI-I to persist. In contl'3Q. the
barrier eff~"Cf exerred by these COnllll~'1 aJ o1pl1isIIls is better
presclVt:d by the use of raI ceph.:u patins,., sugg<:stc.,-d by
13mok [8J. The sc oud is tbe shidding hyp d1C:sis. similarly
proposed by Brook. (J1li.~ theory. caJjed here 'shielding hypodlesi.~·.
,v:-. put forward by A1e.xander Aemmg in 19-16. and was crually
proven Ul rcsp<.'Ct of n'SpU:atory infcco os by Mnddo 'ks and May
[91.) TIllS hypodlCSis 15 b~d on tile proleetloll of . fI)'(~.711'S 3g:l.iru t
peni 'IIm by dll: [3-h cranLlSCS locally rclt':tSed by dler O'PIl~ms
[10.1\ J. h' view, ,l~ based n the obscrvati n d,at more tllJll
75% of tOI15iL~ from patients wltI, reCUfn',nt GABH -ontain
baeteDa produciJlg l>--I; Clalllase. These srr.tins woukl be bener
eradi ted by oral cepllJlosponllS (or a.,n IlS 0 penicillin! with
[3-la 'CUll; se IIIhibiwrs), lhan by peni 'llin, so eliminating the
pr recrive effi t 011 . P~'1/1 P2]. dLs produ 'mg [3-1:JL1:lJ1Ul'>C
<;. ll'iC local p<'ni 'lltn depletion. a l'CMlIl f 3 'sink dfeet'. 111e (3-
L1et;11l\.1,'>C-P luong cell survives the peni '!Iill ch:UJenge. each
mol. ul- f enzyme hydrolyzing a molecule f penicillin substr.tte;
tllen nt'w mole ·lue. conwlS from the environment. wiJl enter the
nve site. Alter a given Dme of bactena-dnlg exposure. this e/fe(.i
should be able effectively 10 rem vc :lIlribioD from dIe
surrounding nVll'Onm 11f. 11llLlar ~ ning n be . pplied I
ther up)XT-rcspiratory era r infecti os rI Il-
he ludding hypothe is is supported by ,Ie. f eradi ,tion
of ,ABHS in dilfercmr type of p. tien . Untreated parien
maine 111 • pyogtllt's in 75% 0 the c. es; 2 p~lacraJlla e
produ el' srraillS wen: ound among 19 pari 'ntS of dill group.
After pcni 'IIin fn.:amlcnt, pcr.oisccn e wa. 55%. and l>--
laCtJ.lll. se producer rganisms were: dere ted in 95% of the
p, ti 'II , suggesting the pr crvati n of dIe P-I tamase-
produ ing ABH -protecting comntunity. 'efj ro~:il treat-
mCllt re ulted in a pcrmten e of only 10% and 13-lacr ma e
producer org:UUSIllS were OUll III only 20% of the patients
1131, ObV1ously the rcs,11 are only indicativc. and ~
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prml'eCllve ~111dy i~ require,I ((l Vl'rit)' the hYI'0lilesis. A
Illllllber o( mysrenl'\ rel11ain in the compar:ltive trearrllellt of
,ABHS \\'llh pCIllC1l1in or onl cephalmponns. For 1I1SlanCI'.
cdiiblltelll, very poorly aCtlVl' agalllSt S. JI),,'gfllfS (MICs 16-32
~lg/llli ). yet It eracllotl's the orgalllslll more frequent! than
docs pellll'llhn V (J I'Y.. VS. H()'Jo(, ... ndicanon).
Alllon~ or:11 cl'JlhalosponllS. cefuroximc I onl' Il( Ihe morc
aeri\'e dnlb"i III I S. 11/Ifl/1II01l;,,,,. In thl' eX ...lIelll mulncl'uler
CllIII,clIon nf thl' AIl'xamler Project (I ')9(,-')7. -I2H(, str-lillS
,tuched). rhl' \'l'tilroxllnl' MIC;lI 'H' for pCIllC1l1m-·u. cpti!>le.
Inremlcdiatl.' or re'lstant smllllS were 0.113/0.0(" 0.51-1 and -I/X
~ll-:/IIIL. rl."pl.'cnvely. A bUlIodJI dlsmbuuou ofsrralrtS IS lixll1d.
With lIlodl' MICs of 11.11) .Ind .~ pg/mL. For cclJd r. the
M Ie ""/11 werl' 11.51 I, 2/16 .Ind (,-1/(,-1 ~lg/I1IL for pelll iUm
IIsceptlbl.... lIlll'nllt·di:n... :md r<:sl.stant straills. r",sl'ectlvdy.
wllJch dl·monsrratl'S.l lower n1l1;nSlC actlVlty o(thl' compound.
The mod ..., of Ihe predOlllll1.lnt popul:mons arc ar 0.5-1 and 6-1
~lg/lllL. For CcflXlIlIe. Ihe tll-'\tres Wl'rl' similar. bm sli~htly
lower Ihall fi.1r .:f.1c1or: 0.25/0.5. 2/16 and 321(,-1 ~lg/rl1L.
WIth two lll11d.t1 MIC p':Jk, .It 0.25 ,1IId :'2 ~lg/lllL.
Acm... otim Ill ...dla dut' lO pelllci.lJIlI-;u, Cl'pnhl.: S. 1""""""·
Iliac I, opunully cured WIth .mlOxyciLltil (100%), hUl oral
cq'halmponllS .loS Cl'l:lclor (90'7;,) and cefuroxim.:-axeril (<) I'Yo)
.• 1", .1"': 11I~hly elleftll'e On [he cOlllrary, l)alYln Jnd co-
workers hal'e shown [15- I71. that penlciLlin-reslst:lIlt pneu-
lllll 'occi respond hell ... r to ,llllOxyclliin (71 'M.) or cetilroxJllle-
axenl (79%) [h.ln to cef: dol' (3H%. no[ dilTerel1\ Irolll
'pOlllanClltH cnre ratl') Th...,t' r.:)uh..11'': COnfinlled in other
smdles. showltlg ·l·ftlroXlIlIl' cure n[l'S 01'92.5%. <)O'Yo Jnd 75')1"
III JCU[C ouns lIll'lhJ .llIs.:d. r... spectlvel', by penl Illin
<usceptible. lntenne,hate or !l'SlstJIII strallls. rhe ,'<)1'1' 'spondnlf-:
tlgllr':< for cc(prozll bl'ing lJH':Ao. lJ(/Yo, and C>H% 11,1 H,I t)l. The
inf1uI'nce of prt'vi IlI\ lr.:atments With JllloxyclI!Jn (ph" I'
minus clavlllau.ltc) 01' c... f.1CI r 011 the <mc"l'tiblhry of
pllcumococCi III acu(c orn;s medIa was srudio:d by Leib virz
e( .11. 1171 Three c.ltq~ori.:s of sllscepnhihty were recordl.'d;
'lr::nns wuh pl'llICllIl1I tllrcrmedl.l[e reslstanc.: (MIC 0.1-1 ~lg/
mL) in reased '-rolll -13% \(l 76''1., Ii-ClIIl nonrrearl't! to prl'vlCHlsly
trearcd 'Itlldr.:n; no ,iglllncint III rease was found for highly
Il'niciliin-rt'<i,tJIH <lr:II11<. Il1lennedlate c<'furoxlllle-rl·'ISl.1t1Ce
(11.5-1 pg/mL) IIIcreased frolll 1)% [(l 37';'(,. and high
cduroxillll' r':'lst,trlce (rom 1(,')1,. ro 2-1 'X. in tre:ltt'd v.
nnntreated panenL<,. .daclor lllt<:l'Il1':lhate reSlSt.lnt \tr.'lIns
(U.5-1 pg/I1lL) increased frolll II % to I(,'Yo: the 11Ighly
rt'Slstalll Strallll IIlcreased fmlll -,O'Yc, to 53%. These ...:sults catl
be easily l·xplallled. H srI'. in. WI[h IIltel'lnedlatc and 11I~h
rl.'sistatlc... to !>l·lllc.lJin have .:vcn higha MI. to cdilr xillle.
and parncularl to cdJ 'lor. This sn~l'sts lhat re ist:lI1ce to oral
cephalmponns lIlay hI' e:lslly selectable by ~-lacral1l agents.
Hal'lllllplll/lis ,,!{lI/l'IIZfl(' IS till: prilllary target resplr. tory
orl-,':Inism for most oral c<:phalllsl'0nIloS. many havlIlg oe.:11
,ksigned tll OVl'l'COml' th.: gro\ ing problelll o( (3-IaCt:llIlJ.I ...
pmducd( n in this speciel. el'l:LinJy th.: wldespn:ad ute of thl'
cOllju~re vaccination will decrease rhe Il11lonancc of that
pathogen. CctlXll11C IS the III It.: :ICtiv.: onl cel halosporul :1~-aIlISt
/-I. ,,!/llIt'IlZfll'. The AI<:xa.ndllr I'rOJ.:ct ,bra of 1'JlJ7 shows that
l)(,'JI" of the StralllS arc IIlhiblred by 0.0(; ~IWl11l (MI ," n.ll. ~IW
lllL). Jnd 99.5'1.. hy O.s Ilg/lllL. thl' hight'Sl MIC being -I p_/mL.
Cl'furoxilll'" i, ablllll 100 tll1Il'S bs pOlt'lH (MIC." I ~g/mL),
with altm\\t ;111 strains inillbll.:d at 0.5-1 ~g/mL: Ih... hlghc~t MI '
recorded \ as 32 ~lg/lllL. CcElcior IS: I() tullCS less actlvc tll:ln
cetilrm:'ll1le; IllOS[ strams rcLjUII~ 2~ ~lg/mL (0 be 1Illubmxl, and
the IlIghe't MIC was 64 l(g/ml.. II tht' ()[her hand. then' a
possible trl'mi tor the decrt'. se 111 rt .•,tan e lor sOllie ral
cephalnspol1m. For imt,lIlCl'. I'rclumnary J.1l.J (rolll the Alcx-
. nd...r PnU<:Cl sut'V.:illal1cc stllt!y IIldlCatl'S tllat 111 the C:LIC of
cef.tclor. till' MI .... W:lS reduced &0111 16 P mL in 1996 (Q
Ilg/IIlL 111 \9'17. and thl' nUl1lber of susc..-poble 'trams IIlcn:ased
dunng the sam... penod from 87% 10 90",{. I 1Ill.'t1ung <imilar
o curr...d "1th c.:furoxll11e. MI ,,, valul'" d<:crt. II1g 'mill -I to 2
Ilg/mL. ,lilt! SllSl''''l'tillc 1<01:11"" in re ing from 'J3% 10 Y6%. <)
,hang.:, were f(ltll1d with cdixirnt' (filily r~l\tant [0 ~-I;Kl.lm.t.....).
99.<)% of the sirains bell1g su.sccptlble during hoth 1')')6 and I'N7.
The rol.: o(Hi.S vaccination in such a trend ne...d, to be e ;plored:
the vaCCIl1.: WIll tend to decrease the II'IClll... I1CC of grOlIp D H.
i,!/I'Io',J'::clo'. \ hlch IS more trequently a (3-1:1 t, 111.15e producer than
other Hm,'/lII'J'"illl str:llm.
A frequent concern abollt oral 'durd-generatioll c.:pl'l.llos-
porins' is th,'ir ;Iblltry to an as sdec:uve .lgenrs tor stTams
h.lrhonng l'xtendcd-spCfrrulll (3-1.1 tamaSt'S III the gut. TIllS
qm.'Slion was .Iddr':'scd recently by Ml'deiro and .rclhn 1201.
The p-l.1et~ma~el T -M-5. T - 1-10 and TEM-2c> produced
MIC l'qual or higher th. II 2 pg/lllL for ,c tiburcn. but the
MICs mediated by T -M-3. 4. ('. 7. ~ and 12 were equ.ll or
h..-Iow I ~lg/ll1L. The relative nsk o(selection should rherefore
Ill' evaluatcd according to the local cpidcrlliology, but at the
ItlOl1h:nf rCI11:lIIlS vc:ry 10\\1.
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